{"transactions":[{"id":1264740,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":83135,"kind":"person","name":"Corrigan Brian","position":1,"cik":"0002032323","reported_name":"Corrigan Brian","relationship":{"officer":true,"officer_title":"SVP, Regulatory & QA"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T21:18:38.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":448660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":448660,"derivative":{"underlying":"Common Stock","underlying_shares":448660},"source":{"system":"sec-edgar","filing":"0001127602-25-005213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005213/form4.xml","form_type":"4"}},{"id":1264739,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":83135,"kind":"person","name":"Corrigan Brian","position":1,"cik":"0002032323","reported_name":"Corrigan Brian","relationship":{"officer":true,"officer_title":"SVP, Regulatory & QA"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:18:38.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":673000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":673000,"derivative":{"exercise_price":0.695,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":673000},"source":{"system":"sec-edgar","filing":"0001127602-25-005213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005213/form4.xml","form_type":"4"}},{"id":1436260,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":83135,"kind":"person","name":"Corrigan Brian","position":1,"cik":"0002032323","reported_name":"Corrigan Brian","relationship":{"officer":true,"officer_title":"SVP, Regulatory & QA"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-12T12:40:16.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":200000,"derivative":{"exercise_price":1.6,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-24-021967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224021967/form4.xml","form_type":"4"}}]}